An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Experimental Drug Gaining Popularity Online
The experimental drug, which remains in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these accounts directly for supplier links, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and claims of rapid UK delivery. Sellers promote the drug there before directing buyers to other platforms for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.
Several professionals said the demand for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Platform Response and Content Elimination
Based on TikTok, the platform has removed problematic material and banned related hashtags and query recommendations. The company stated it was dedicated to keeping the service safe and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also found communities with up to nine thousand participants selling the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with numerous of users, filled with photos of weight loss, glowing testimonials and step-by-step instructions for preparing or administering at residence.
Within minutes of joining one community, a vendor shared WhatsApp details, where the majority of transactions take place. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about body mass, health issues or previous experience.
Item Details and Pricing
Inside these communities, posts display dark colored packages with postal service stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, mixed at home with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When questioned how long a pen should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Service Oversight and Security Measures
A representative for the messaging service said it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they can’t verify. Although the research behind this drug is sound, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are using social media. But counterfeit treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has already seen individuals harmed by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose patients to potentially significant medical dangers”.
